AcuraStem is a patient-based biotechnology company pioneering treatments for neurodegenerative diseases, including ALS and FTD. AcuraStem’s best-in-class disease modeling platform, iNeuroRx, enables the discovery of innovative, effective, and broadly acting treatments. The team’s strong expertise in ASO technology provides for the rapid advancement of treatments in the clinic. AcuraStem’s research is funded in part by support from the Alzheimer’s...
